BioMelbourne Network Progressing BioIndustry

• Home
• About Us
• Events
• Grants & Awards
• News & Opinion
• Membership
• VicBioPortal
• Resource Library
• Contact

12th December 2013 - Brisbane.   Provides infrastructure for CardioCel® production Provides an instant, highly skilled and experienced production team Accelerates scale up manufacturing of CardioCel® for global markets Admedus, formerly Allied Healthcare Group (ASX: AHZ) today announced that it has signed a share purchase agreement to acquire an established manufacturing site from Genzyme ... read more…

12 December 2013 - • Hatchtech receives FDA agreement of its DeOvo Phase III study design via the Special Protocol Assessment (SPA) process allowing for the commencement of two pivotal studies in early 2014;• Additional Hatchtech patents allowed in Europe and Japan which further strengthens the commercial protection of DeOvo internationally. Hatchtech today announced that it has received fina... read more…

12 December -   • Australian scientists developed new feed inclusion supplement that reduced antibiotic use on-farm• MMA selling Udder-Mate® in Australia and New Zealand Australian drug delivery technology company Phosphagenics Limited (ASX:POH; OTCQX:PPGNY), with its licensee Mastitis Management Australia (MMA), today announced that MMA’s Udder-Mate® feed inclusion technology, which includes... read more…

6th December - $500,000 fund to promote tech collaborations between Victoria and Israel Victorian businesses or research organisations seeking collaborations with partners in Israel will be one step closer today, with the announcement of grants of up to $50,000 as part of the Victoria Israel Feasibility and Proof of Concept (VISFPC) grants. Minister for Innovation, Services and Small Business... read more…

December 5 2013.  CSL Limited has today announced an agreement with Janssen Biotech, Inc. that may one day lead to new treatments for haematological cancers and autoimmune diseases.The agreement grants Janssen an exclusive worldwide license to develop and commercialise CSL362, a novel monoclonal antibody therapy. Currently, CSL362 is being studied in a Phase 1 clinical trial in acute myeloid le... read more…

4th December, 2013 - Prostate Cancer Foundation of Australia (PCFA) has announced the recipients of the latest research funds as part of the Movember-funded National Research Program. The top ten of sixty researchers from across the country have been selected to receive funding as part of PCFA’s New Concept and the Young Investigators grant categories. Senior Researchers who have been offered... read more…

3rd December, 2013 - Asian countries outperform the rest of the world in the OECD’s latest PISA survey, which evaluates the knowledge and skills of the world’s 15-year-olds. The OECD’s PISA 2012 tested more than 510,000 students in 65 countries and economies on maths, reading and science. The main focus was on maths. Math proficiency is a strong predictor of positive outcomes for young adults.... read more…

25th November - Movember Request for Proposals: $8 million is available for collaborative, innovative mental health projects The Movember Foundation is now seeking proposals from organisations that wish to collaboratively develop new projects for mental health programs that will contribute to change at the population level, with a specific focus on prevention, early intervention and stigma red... read more…

18th November 2013, Melbourne: • IDT Australia Limited (ASX:IDT) has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market temozolomide capsules• The temozolomide market is large (US$996 million) and IDT seeks to capitalise the opportunity to manufacture generic products as temozolomide comes off patent next year • This ini... read more…

14th November, 2013 - GlaxoSmithKline has awarded Professor Ingrid Scheffer the 2013 Award for Research Excellence (ARE) for helping to transform the diagnosis of epilepsy. GSK Medical Director Dr Andrew Yeates says Professor Scheffer’s clinical research has resulted in the identification of several new epilepsy syndromes and has led directly to the discovery of new causative genes. “This all... read more…

11th November, 2013 - The Monash Institute of Pharmaceutical Sciences (MIPS) has been recognised for the Monash-GSK Australian Centre for Innovation and Industrialisation project, a unique research and development partnership that is delivering advanced medicines to the world. Presented with the National Business Higher Education Round Table (B-HERT) Award for the Best Research and Development... read more…

11th November, 2013 - Melbourne, Australia and Hamburg, Germany: A novel drug which assists neurosurgeons to better visualise and remove malignant brain tumours has been approved by the Therapeutic Goods Administration (TGA). • Novel drug which improves visualisation and resection of malignant brain tumours now widely available • Twice as many patients are without progression of brain cancer s... read more…

8th November 2013 - Australia’s research and innovation sector will receive a $522 million boost with Minister for Education, Christopher Pyne today announcing 1177 new research projects funded by the Australia Research Council (ARC). The funding has been announced as part of the ARC’s Future Fellowships scheme(commencing 2013) and major grants schemes (commencing 2014). The schemes for which... read more…

5th November, 2013 - A pioneer of research in organic electronics, Professor Andrew Holmes, has been elected as the next President of the Australian Academy of Science. He will assume the role after the Academy’s next Annual General Meeting in May 2014. The presidency alternates between the physical and biological sciences and the term lasts for 4 years. Professor Holmes is a Laureate Professo... read more…

30th October - Fighting cancer by the numbers.Terry Speed doesn’t expect to see headlines reading “Statistician cures cancer” any time soon. But he knows that the right mathematics and statistics can help researchers understand the underlying causes of cancer and reduce the need for surgery. A mathematician and statistician, he has written elegant theoretical papers that almost no-one reads. B... read more…

24 October 2013, Melbourne - Oxymorphone patch achieves world first therapeutic plasma concentrations in all subjects in clinical trial Results from Phase 1 oxymorphone patch clinical trial demonstrates excellent drug delivery profile Most commercially significant trial result ever achieved by Phosphagenics as it proves the concept for an estimated $1 billion annual sales Phase 2 study to... read more…

Brisbane, Australia, 23rd October 2013  Rights Issue $6M over subscribed Over 70% of shareholders take up entitlement All shortfall allocated to existing shareholders Allied Healthcare Group (ASX: AHZ) (Company) advises that the non-renounceable rights offer announced on 23 September 2013 to raise approximately $10.4 million (before expenses) on the basis of 1 new fully paid ordinary sh... read more…

9th October, 2013 - Professor Lloyd Hollenberg from the University of Melbourne and Professor Alan Cowman from the Walter and Eliza Hall Institute, have both been awarded the 2013 Victoria Prize for Science and Innovation – worth $50,000 each. Minister for Innovation, Services and Small Business Louise Asher today presented the awards at a ceremony in Melbourne. Receiving the Victoria Prize f... read more…

Australia is ranked 7th in world by Scientific American magazine in terms of biotechnology innovation*1.  Does that surprise you?  13 Nobel Prizes in physiology, physics and chemistry (one in literature). The bionic ear, WiFi, IVF, Relenza®, Gardasil® - the list of science success stories is pretty impressive.  Australia has certainly grown-up some big names in science too.  This evidence cert... read more…

The Victorian Infection and Immunity Network Industry Alliance has a number of $20,000 grants for Collaborative Projects between Victorian researchers and Victorian-based industry partners.This is the second round of funding for Collaborative Projects on infectious disease and immunity as it relates to infection. Applications are invited from all Victorian infection and immunity researchers an... read more…